Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Aurinia Pharmaceuticals Inc. (AUPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/21/2023 4 Bailey Jeffrey Allen (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 17,913 restricted stock units @ $0
Granted 28,959 options to buy @ $9.49, valued at $274.8k
08/21/2023 3 Bailey Jeffrey Allen (Director) has filed a Form 3 on Aurinia Pharmaceuticals Inc.
08/21/2023 4 Smith Karen L. (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 17,913 restricted stock units @ $0
Granted 28,959 options to buy @ $9.49, valued at $274.8k
08/21/2023 3 Smith Karen L. (Director) has filed a Form 3 on Aurinia Pharmaceuticals Inc.
05/23/2023 4 Balakrishnan Brinda (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 9,310 shares @ $0
Exercised 8,733 restricted stock units @ $0
Granted 15,234 options to buy @ $10.74, valued at $163.6k
05/23/2023 4 Jayne David R.W. (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 9,310 shares @ $0
Sold 8,733 shares @ $11.26, valued at $98.3k
Exercised 8,733 restricted stock units @ $0
Granted 15,234 options to buy @ $10.74, valued at $163.6k
05/23/2023 4 Hagan Joseph P (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Sold 272 shares @ $10.58, valued at $2.9k
Exercised 8,733 restricted stock units @ $0
05/23/2023 4 Billen Daniel (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 9,310 shares @ $0
Sold 4,650 shares @ $11.26, valued at $52.4k
Exercised 8,733 restricted stock units @ $0
Granted 15,234 options to buy @ $10.74, valued at $163.6k
05/23/2023 4 MILNE GEORGE M JR (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Exercised 8,733 restricted stock units @ $0
05/23/2023 4 MacKay-Dunn R. Hector (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 9,310 shares @ $0
Sold 4,818 shares @ $11.26, valued at $54.3k
Exercised 8,733 restricted stock units @ $0
Granted 15,234 options to buy @ $10.74, valued at $163.6k
05/23/2023 4 Leversage Jill (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 9,310 shares @ $0
Sold 4,815 shares @ $11.26, valued at $54.2k
Exercised 8,733 restricted stock units @ $0
Granted 15,234 options to buy @ $10.74, valued at $163.6k
03/06/2023 4 MILNE GEORGE M JR (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Bought 20,000 shares @ $8.9142, valued at $178.3k
03/06/2023 4 Donley Matthew Maxwell (EVP, Ops & Strategy) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 271,134 shares @ $0
03/06/2023 4 Miller Joseph M (CFO) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 229,421 shares @ $0
Sold 11,296 shares @ $8.94, valued at $101k
03/06/2023 4 Robertson Stephen P. (EVP, General Counsel) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 204,810 shares @ $0
Sold 19,402 shares @ $8.94, valued at $173.5k
03/06/2023 4 Martin Michael Robert (Chief Business Officer) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 107,202 shares @ $0
03/06/2023 4 Habig Scott Michael (Chief Commercial Officer) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 170,188 shares @ $0
03/06/2023 4 Knappertz Volker (EVP, Research and Development) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 191,462 shares @ $0
03/06/2023 4 Greenleaf Peter (CEO) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 667,407 shares @ $0
Sold 32,750 shares @ $8.94, valued at $292.8k
11/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/14/2022 4 Habig Scott Michael (Chief Commercial Officer) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Bought 5,000 shares @ $5.015, valued at $25.1k
11/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2022 4 Knappertz Volker (EVP, Research and Development) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 256,892 options to buy @ $8.18, valued at $2.1M
Granted 152,812 restricted stock units @ $0
08/01/2022 4 Habig Scott Michael (Chief Commercial Officer) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 231,203 options to buy @ $8.18, valued at $1.9M
Granted 137,531 restricted stock units @ $0
07/19/2022 3 Knappertz Volker (EVP, Research and Development) has filed a Form 3 on Aurinia Pharmaceuticals Inc.
07/19/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
07/11/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/20/2022 4 Balakrishnan Brinda (Director) has filed a Form 4 on Aurinia Pharmaceuticals Inc.
Txns: Granted 8,733 restricted stock units @ $0
Granted 14,612 options to buy @ $11.45, valued at $167.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy